Kelly Narine
Directeur Technique/Scientifique/R&D chez CARDIOL THERAPEUTICS INC.
Profil
Kelly Narine is currently the Director of Medical Affairs at Cardiol Therapeutics, Inc. and an Independent Director at Neural Therapeutics, Inc. Previously, she worked as the Director of Clinical Affairs at Afexa Life Sciences, Inc. and as the Vice President of Research at Aurora Cannabis, Inc. She received her doctorate degree from the University of Alberta in 2008.
Postes actifs de Kelly Narine
| Sociétés | Poste | Début |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/10/2020 |
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kelly Narine
| Sociétés | Poste | Fin |
|---|---|---|
Afexa Life Sciences, Inc.
 Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Directeur Technique/Scientifique/R&D | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
Formation de Kelly Narine
| University of Alberta | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AURORA CANNABIS INC. | Process Industries |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neural Therapeutics, Inc.
Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Health Technology |
Afexa Life Sciences, Inc.
Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Commercial Services |
